Congress Large Cap Growth ETF (NYSEARCA:CAML – Get Free Report) saw a significant decrease in short interest in August. As of August 31st, there was short interest totaling 232 shares, a decrease of 95.1% from the August 15th total of 4,782 shares. Based on an average daily volume of 26,064 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the company’s shares are short sold.
Congress Large Cap Growth ETF Stock Performance
Congress Large Cap Growth ETF stock traded up $0.53 during midday trading on Friday, hitting $40.04. 13,162 shares of the company’s stock were exchanged, compared to its average volume of 28,398. The company has a market cap of $378.78 million, a PE ratio of -1,001.00 and a beta of 1.10. The firm has a 50-day moving average of $40.22 and a two-hundred day moving average of $38.89. Congress Large Cap Growth ETF has a 12 month low of $33.89 and a 12 month high of $42.05.
Institutional Investors Weigh In On Congress Large Cap Growth ETF
An institutional investor recently bought a new stake in Congress Large Cap Growth ETF stock. JPMorgan Chase & Co. purchased a new position in shares of Congress Large Cap Growth ETF (NYSEARCA:CAML – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,356 shares of the company’s stock, valued at approximately $91,000.
Congress Large Cap Growth ETF Company Profile
The Congress Large Cap Growth ETF (CAML) is an exchange-traded fund that mostly invests in large cap equity. The fund is an actively managed fund that seeks long-term capital growth through investments in large-cap companies believed to be experiencing or will experience earnings growth. CAML was launched on Aug 22, 2023 and is issued by Congress.
Featured Stories
- Five stocks we like better than Congress Large Cap Growth ETF
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Congress Large Cap Growth ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Congress Large Cap Growth ETF and related companies with MarketBeat.com's FREE daily email newsletter.
